Literature DB >> 19506209

Infliximab therapy for refractory uveitis: 2-year results of a prospective trial.

Eric B Suhler, Justine R Smith, Tracy R Giles, Andreas K Lauer, Michael S Wertheim, Daryl E Kurz, Paul A Kurz, Lyndell Lim, Friederike Mackensen, Terri D Pickard, James T Rosenbaum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19506209     DOI： 10.1001/archophthalmol.2009.141

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  33 in total

1.  Why HLA-B27? My thirty-year quest: the Friedenwald lecture.

Authors:  James T Rosenbaum
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-29       Impact factor: 4.799

Review 2.  Ocular Sarcoidosis.

Authors:  Sirichai Pasadhika; James T Rosenbaum
Journal:  Clin Chest Med       Date:  2015-12       Impact factor: 2.878

3.  Infliximab for progressive peripheral ulcerative keratitis in a patient with juvenile rheumatoid arthritis.

Authors:  Joo Youn Oh; Mee Kum Kim; Won Ryang Wee
Journal:  Jpn J Ophthalmol       Date:  2011-02-18       Impact factor: 2.447

Review 4.  Clinical trials in noninfectious uveitis.

Authors:  Jane S Kim; Jared E Knickelbein; Robert B Nussenblatt; H Nida Sen
Journal:  Int Ophthalmol Clin       Date:  2015

Review 5.  Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview.

Authors:  Éric Toussirot; François Aubin
Journal:  RMD Open       Date:  2016-07-15

6.  [DOG and BVA guideline no. 24b : Noninfectious uveitis posterior].

Authors: 
Journal:  Ophthalmologe       Date:  2017-12       Impact factor: 1.059

Review 7.  The Use of Biologic Therapies in Uveitis.

Authors:  Sergio Schwartzman; Monica Schwartzman
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

8.  Angiogenic and Immunologic Proteins Identified by Deep Proteomic Profiling of Human Retinal and Choroidal Vascular Endothelial Cells: Potential Targets for New Biologic Drugs.

Authors:  Justine R Smith; Larry L David; Binoy Appukuttan; Phillip A Wilmarth
Journal:  Am J Ophthalmol       Date:  2018-03-17       Impact factor: 5.258

Review 9.  Pharmacotherapy of scleritis: current paradigms and future directions.

Authors:  Robert M Beardsley; Eric B Suhler; James T Rosenbaum; Phoebe Lin
Journal:  Expert Opin Pharmacother       Date:  2013-02-21       Impact factor: 3.889

10.  Bilateral Idiopathic Solitary Granuloma of the Uveal Tract: Diagnosis and Treatment.

Authors:  Wonchon Lin; Robert M Beardsley; Alison H Skalet; David J Wilson; James T Rosenbaum; Phoebe Lin
Journal:  Int J Ophthalmic Pathol       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.